HROW FY 2016 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

FY 2016 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$20M+105.2% YoY

Gross Profit

$10M50.7% margin

Operating Income

-$16M-79.6% margin

Net Income

-$19M-95.7% margin

EPS (Diluted)

$-1.50

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$18M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$27M

Total Liabilities

$21M

Stockholders' Equity

$6M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20M	$10M	+105.2%
Gross Profit	$10M	$5M	+124.2%
Operating Income	-$16M	-$15M	-7.2%
Net Income	-$19M	-$16M	-20.1%